Metabolic testing market

Metabolic Testing Market, by Product Type (Metabolic Carts (Portable and Bench-top), Body Composition Analyzers (Portable and Bench-top), and ECGs/EKGs (Portable and Bench-top)), by Test Type (VO2 Max Analysis, RMR Analysis, and Body Composition Analysis), by End User (Hospitals & Clinics, Sports Performance Lab, and Home Care Settings), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Request Free Sample

Aug 2022
CMI1652
179 Pages
Excel & Pdf
Clinical Diagnostic

Summary

Metabolic testing involves assessment of health and wellbeing of an individual. Metabolic testing equipment are used to screen organ functions and disease conditions such as liver diseases, diabetes, kidney diseases, and cardiovascular diseases. Metabolism is a chemical reaction occurring in the body to maintain the standard state of the organism or body. Metabolic syndrome is a group of metabolic disorders such as high blood pressure with high fasting glucose levels and abnormal obesity. Metabolism pattern and metabolic capacity is determined with the help of metabolic testing for management of such conditions. In case of sports professionals, metabolic testing is done in order to test the body’s ability of oxygen consumption.

Global metabolic testing market size was valued at US$ 596.3 million in 2022 and is expected to witness a CAGR of 7.6 % over the forecast period (2022 – 2030).

Figure 1. Global Metabolic Testing Market Share (%), by Product type, 2022

Increasing launch of metabolic carts by market players is expected to propel demand for metabolic testing devices.

Metabolic testing market is expected to witness significant growth over the forecast period, owing to increasing launches of new metabolic carts. For instance, on May, 2021, Lumen ,a health tech company, had officially been peer-reviewed and published in the Interactive Journal of Medical Research (I-JMR). In collaboration with San Francisco State University, Lumen had validated an ongoing study launched in 2020, which showed the validity of Lumen to detect changes in metabolic fuel utilization in a comparable manner with a laboratory standard metabolic cart, providing the ability for real-time metabolic information for users under any circumstances. Lumen has made metabolic testing accessible to measure metabolism from home via the CO2 exhaled from the breath.

Metabolic Testing Market Report Coverage

Report Coverage	Details
Base Year:	2021	Market Size in 2022:	US$ 596.3 Mn
Historical Data for:	2017 to 2020	Forecast Period:	2022 to 2030
Forecast Period 2022 to 2030 CAGR:	7.6%	2030 Value Projection:	US$ 1,074.9 Mn
Geographies covered:	North America: U.S. and Canada Latin America: Brazil, Argentina, Mexico, and Rest of Latin America Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific Middle East: GCC Countries, Israel, and Rest of Middle East Africa: South Africa, North Africa, and Central Africa
Segments covered:	By Product Type: Metabolic Carts (Portable, Bench-top), Body Composition Analyzers (Portable, Bench-top), ECGs/EKGs (Portable, Bench-top) By Test Type: VO2 Max Analysis, RMR Analysis, Body Composition Analysis By End User: Hospital & Clinics, Sport Performance Lab, Home Care Setting
Companies covered:	COSMED srl, Vyaire Medical, Inc., Geratherm Medical AG, MGC Diagnostics Corporation, CORTEX Biophysik GmbH, General Electric Company, Microlife Medical Home Solutions, Inc., OSI Systems, Inc., AEI Technologies, Inc., KORR Medical Technologies, Inc., Iworx Systems, GE Healthcare, Hologic, Inc, Geratherm Medical AG, and Parvo Medics.
Growth Drivers:	Increasing launch of metabolic carts by market players Increasing prevalence of lifestyle diseases
Restraints & Challenges:	Low awareness among people regarding metabolic testing

Figure 2. Global Metabolic Testing Market Share (%), by Region, 2022

Increasing prevalence of lifestyle diseases is expected to propel demand for metabolic testing devices.

Metabolic testing market is expected to witness significant growth over the forecast period, owing to increasing prevalence of lifestyle diseases such as type 2 diabetes, obesity, and cardiovascular diseases. For instance, on July 28, 2022 according to American Diabetes Association (ADA), in 2019, around 37.3 million people in the U.S. were suffering from diabetes. Whereas, nearly 1.9 million U.S. people had type 1 diabetes, including about 244,000 children and adolescents. Increasing prevalence of lifestyle diseases leads to high demand for metabolic testing, which in turn is expected to boost the global metabolic testing market growth.

Therefore, high prevalence of diabetes is expected to drive the global metabolic testing market growth over the forecast period.

Global Metabolic Testing Market– Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization had declared it a public health emergency on January 30, 2020.

Increasing use of electrocardiography in coronavirus disease 2019 (COVID-19) has driven growth of the global metabolic testing market over the forecast period. For instance, in August 2020, National Center for Biotechnology Information, National Library of Medicine, published a report on Value of electrocardiography in coronavirus disease 2019 (COVID-19), which stated that electrocardiogram monitoring upholds a critical role in patient safety during the dose adjustment of medications used in the management of COVID-19. The electrocardiogram (ECG) is one of the major tools to assess the extent of cardiac involvement in COVID-19 patients, due to low cost, and the possibility of remote evaluation.

Hence use of electrocardiogram in covid-19 has driven growth of the global metabolic testing market over the forecast period.

Global Metabolic Testing Market: Key Developments

Increasing adoption of new technologies in metabolic testing devices is expected to drive growth of the global metabolic testing market. On May 1, 2022, Mayo Clinic, a medical center focused on integrated health care, education, and research, developed a new app for Apple, a multinational technology company, using Artificial Intelligence to Detect Left-Ventricular Dysfunction, a life-threatening, asymptomatic heart disease. The introduction of ArtificiaI intelligence to 12 lead ECG (Electrocardiogram) analysis in a clinical setting enabled the ECG to identify left ventricular dysfunction. The technology has the potential to be scaled and adopted by hospital systems to better serve patients, particularly in remote communities or geographically diverse populations around the world.
Increasing launches of metabolic testing devices by market players boosts growth of the global metabolic testing market. For instance, on January 26, 2022 , Royal Philips, a global health technology company, announced the introduction of the full-service, at-home, 12-lead electrocardiogram (ECG) solution for use in decentralized clinical trials. The clinical-grade solution enables patient-centric ECG offering within the company’s cardiac monitoring portfolio, pairing data readings comparable to clinical, site-based ECGs with Philips, a cloud-based data collection and analysis services company, which in turns helps to drive innovation across the care continuum and support the decentralized clinical trial space.

Global Metabolic Testing Market Restraints

Lifestyle diseases are still not considered as extremely serious and fatal in developed as well as emerging economies. Low awareness among people regarding metabolic testing and need for screening, prevention, and monitoring of lifestyle diseases is also expected to restrain the market growth.

Two tests are majorly conducted/used in metabolic testing. Resting Metabolic Rate (RMR) analysis is required in ICUs (Intensive care units) for hospitalized patients to track their health status and to devise precise nutritional requirements for such patients on the basis of their RMR analysis. VO2 max analysis is required by sports professionals and athletes so, these two tests have limited target population which may restrain growth of market. Body composition analysis is not performed extensively other than by fitness enthusiasts (to have high muscle to fat ratio for a muscular physique) and other purposes. These factors are expected to restrain growth of market to a certain extent.

Key Players

Key players operating in the global metabolic testing market include COSMED srl, Vyaire Medical, Inc., Geratherm Medical AG, MGC Diagnostics Corporation, CORTEX Biophysik GmbH, General Electric Company, Microlife Medical Home Solutions, Inc., OSI Systems, Inc., AEI Technologies, Inc., KORR Medical Technologies, Inc., Iworx Systems, GE Healthcare, Hologic, Inc, Geratherm Medical AG, and Parvo Medics.

Table of Content

Table of Contents

*Browse 35 market data tables and 34 figures on “Global Metabolic Testing Market” -Global forecast to 2030

Segmentation

Detailed Segmentation:

- Frequently Asked Questions -

What are the growth estimates for global metabolic testing market till 2030?

Global metabolic testing market is estimated to surpass US$ 1,074.9 Million by 2030.

Which are the prominent market players across the globe?

Major players operating in the market include COSMED srl, Vyaire Medical, Inc., Geratherm Medical AG, MGC Diagnostics Corporation, CORTEX Biophysik GmbH, General Electric Company, Microlife Medical Home Solutions, Inc., OSI Systems, Inc., AEI Technologies, Inc., KORR Medical Technologies, Inc., Iworx Systems, GE Healthcare, Hologic, Inc, Geratherm Medical AG, and Parvo Medics.

Which segment based on Product type, accounted for the highest demand in global metabolic testing devices in 2022?

Among Product Type, Metabolic cart segment generated significant revenue in 2022, owing to increasing launches of metabolic carts by market players.

What are the key factors driving growth of the market?

Increasing prevalence of lifestyle diseases is expected to propel demand for metabolic testing devices.

What is the Compound Annual Growth Rate (CAGR) of the market till 2030?

The market is estimated to exhibit a CAGR of 7.6 % over the forecast period.

Which region is dominating the market growth?

Among regions, North America is expected to witness significant growth over the forecast period, owing to increasing prevalence of lifestyle diseases such as cardiovascular disease, diabetes and obesity.